AmealPeptide® At-A-Glance

• How is it made?
• Regulatory status
• Patents
• Where does AmealPeptide® come from and is it high quality?
• Availability
• Price

How is it made?

AmealPeptide® is produced by enzymatic hydrolysis of casein, a component of nonfat milk.

Regulatory status

AmealPeptide® is a self-GRAS (Generally Recognized As Safe) ingredient. It has been evaluated by a panel of experts who are qualified by experience and training, and who have determined it to be safe.

Patents

Below are the main patents that relate to AmealPeptide®.

[Patent on producing and using AmealPeptide® for ACEI]
Title: Angiotensin converting enzyme inhibitor and method for preparing same
Pat. US5449661 (Sep. 12, 1995)
Foreign Application Priority Data (Jul. 23, 1992)

[Additional patent on production and usage of AmealPeptide®]
Title: Method for preparing antihypertensive agent
Pat. US5854029 (Dec. 29, 1998)
Foreign Application Priority Data (Aug. 2, 1996)

[Patent for producing AmealPeptide® with enzyme]
Title: Process for producing tripeptides
Pat. WO 01/34828 A1 (May. 17, 2001)
Foreign Application Priority Data (Nov. 11, 1999)

Title: Casein hydrosate, method for preparing the same, and use thereof
(Patent pending)

Where does AmealPeptide® come from and is it high quality?

AmealPeptide® is manufactured at a technologically advanced and hygienic facility in Denmark, a country generally considered to be environmentally advanced.

AmealPeptide® is manufactured at an ISO9001-standard-compliant, HACCP-certified facility under a strict quality assurance system.

AmealPeptide® has a Kosher certification and is manufactured under the supervision of the Kashruth Division of the Orthodox Union.

Availability

AmealPeptide® is available as a dry, white, spray-dried powder packaged in a 15-kilogram, high-barrier polyethylene bag.

Price

Price and availability are dependent on various factors (i.e., quantity, timing, etc.). For detailed information, please contact info@amealpeptide.com.